Darsh Pharmachem

Kheda, India Founded: 2016 • Age: 10 yrs
Manufactures active pharmaceutical ingredients and advance intermediates through research and production processes.

About Darsh Pharmachem

Darsh Pharmachem is a Healthcare company based in Kheda (India) founded in 2016. It manufactures active pharmaceutical ingredients and advance intermediates through research and production processes. It operates on a B2B model in Healthcare and Chemicals & Materials sectors. The company has 29 employees. Its Indian entity Darsh Pharmachem Private Limited reported revenue of β‚Ή14.50 Cr. Darsh Pharmachem offers products and services including Agomelatine, Brinzolamide, Ivabradine, Milnacipran Hydrochloride, and Levomilnacipran Hydrochloride. Its focus areas include Pharmaceuticals, API Manufacturing, Active Pharmaceutical Ingredients and Chemicals and Materials. Similar companies include Entero Healthcare, Keimed and Sandor Medicaids; 3 of its 3 listed similar companies have raised funding.

Company details

Darsh Pharmachem is a pharmaceutical company incorporated in 2016, specializing in the production of active pharmaceutical ingredients and advanced intermediates. It operates a state-of-the-art manufacturing facility in Gujarat, India, focusing on research, process chemistry, and quality management to deliver safe and effective products. The company emphasizes vertical integration and adheres to GMP regulations, serving clients in the global pharmaceutical industry through reliable supply chains.

  • Headquarters Kheda, India
  • Employees 29
  • Sectors
    Healthcare
    Chemicals & Materials
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website darshpharmachem.com
  • Legal Name Darsh Pharmachem Private Limited
  • Date of Incorporation 28 Apr, 2016
  • Jurisdiction Mahemdabad, Gujarat, India
Key Metrics
  • Annual Revenue
    ₹14.50 Cr

    FY 2024 · -53% YoY

  • Net Loss
    -₹1.15 Cr

    FY 2024 · -8% margin

  • EBITDA
    ₹2.67 Cr

    FY 2024 · 18% margin

  • Employee Count
    29

Products & Services of Darsh Pharmachem

Darsh Pharmachem offers a comprehensive portfolio of products and services, including Agomelatine, Brinzolamide, Ivabradine, Milnacipran Hydrochloride, and Levomilnacipran Hydrochloride.

Agomelatine
API

Active ingredient used in antidepressant medications for treating mood disorders

Brinzolamide
API

Active ingredient for eye care treatments to reduce intraocular pressure

Ivabradine
API

Active ingredient for heart conditions to regulate heart rate effectively

Milnacipran Hydrochloride
API

Active ingredient for managing fibromyalgia and chronic pain symptoms

Levomilnacipran Hydrochloride
API

Active ingredient in medications for major depressive disorder

Board of directors of Darsh Pharmachem Private Limited (Darsh Pharmachem)

Darsh Pharmachem Private Limited is the primary company behind Darsh Pharmachem. The board of Darsh Pharmachem Private Limited currently have 4 directors; the longest-serving is Himanshukumar Jayantibhai Patel, appointed in 2016. 6 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Himanshukumar Jayantibhai Patel
DIN 07173641
Director28 Apr 201610 yrs 5 moDarsh Pharmachem Private Limited
Ramnikbhai Nanjibhai Patel
DIN 07492543
Director28 Apr 201610 yrs 5 moDarsh Pharmachem Private Limited
Sureshbhai Bhalabhai Patel
DIN 08026276
Director29 Jan 20188 yrs 8 moDarsh Pharmachem Private Limited
Jaimini Himanshu Patel
DIN 07798590
Director11 Oct 20215 yrsDarsh Pharmachem Private Limited

Financials of Darsh Pharmachem

Figures of Darsh Pharmachem Private Limited, the primary company behind Darsh Pharmachem, for FY 2024. Revenue was ₹14.50 Cr (-53% year on year). Net loss was -₹1.15 Cr (-8% margin). EBITDA was ₹2.67 Cr (18% margin). Revenue has grown at a compounded annual rate of -6% over three years and +20% over five years.

  • ₹14.50 CrRevenue · FY 2024 · -53% YoY
  • -₹1.15 CrNet loss · -8% margin
  • ₹2.67 CrEBITDA · 18% margin
  • ₹4.90 CrPaid-up capital
  • 29Employees (provident fund records)
  • -6%Revenue CAGR, 3 years
  • +20%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Darsh Pharmachem Private Limited are on its company page.

Premium access

Detailed financial statements for Darsh Pharmachem

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Darsh Pharmachem

Darsh Pharmachem has 3 listed similar companies in our database, 3 of them funded. They include Entero Healthcare, Keimed and Sandor Medicaids.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
enterohealthcare.com2018Mumbai, India$59.67M817
India's leading healthcare products distribution platform
keimed.com2000Hyderabad, India$16.62M588
Temperature-sensitive medicines are distributed via cold chain logistics by Keimed.
sandor.co.in1995Hyderabad, India$8.98M161
Provider of medical equipment, devices, and drugs distribution services
Premium access

Detailed similar companies of Darsh Pharmachem

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Darsh Pharmachem

Darsh Pharmachem was founded in 2016.

Darsh Pharmachem is headquartered in Kheda, India. It is registered at Kheda, Gujarat, India.

Darsh Pharmachem has 29 employees.

The primary company behind Darsh Pharmachem, Darsh Pharmachem Private Limited, reported revenue of β‚Ή14.50 Cr for FY 2024, down 53% year on year.

Darsh Pharmachem is a pharmaceutical company incorporated in 2016, specializing in the production of active pharmaceutical ingredients and advanced intermediates. It operates a state-of-the-art manufacturing facility in Gujarat, India, focusing on research, process chemistry, and quality management to deliver safe and effective products. The company emphasizes vertical integration and adheres to GMP regulations, serving clients in the global pharmaceutical industry through reliable supply chains.

Darsh Pharmachem's top competitors include Entero Healthcare, Keimed and Sandor Medicaids.

Darsh Pharmachem offers Agomelatine, Brinzolamide, Ivabradine, Milnacipran Hydrochloride, and Levomilnacipran Hydrochloride.

Darsh Pharmachem operates through Darsh Pharmachem Private Limited.

The legal entities of Darsh Pharmachem currently have 4 directors, including Himanshukumar Jayantibhai Patel, Sureshbhai Bhalabhai Patel, Jaimini Himanshu Patel and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available